Poseida Therapeutics Inc (PSTX)
2.73
+0.02
(+0.74%)
USD |
NASDAQ |
Nov 22, 16:00
2.86
+0.13
(+4.76%)
After-Hours: 20:00
Poseida Therapeutics Total Liabilities (Quarterly): 206.37M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 206.37M |
| June 30, 2024 | 237.87M |
| March 31, 2024 | 177.99M |
| December 31, 2023 | 170.18M |
| September 30, 2023 | 178.59M |
| June 30, 2023 | 145.91M |
| March 31, 2023 | 156.06M |
| December 31, 2022 | 164.24M |
| September 30, 2022 | 164.17M |
| June 30, 2022 | 139.66M |
| Date | Value |
|---|---|
| March 31, 2022 | 144.45M |
| December 31, 2021 | 113.10M |
| September 30, 2021 | 111.78M |
| June 30, 2021 | 112.54M |
| March 31, 2021 | 105.85M |
| December 31, 2020 | 109.52M |
| September 30, 2020 | 109.34M |
| June 30, 2020 | 431.66M |
| March 31, 2020 | 109.26M |
| December 31, 2019 | 296.51M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
105.85M
Minimum
Mar 2021
431.66M
Maximum
Jun 2020
169.25M
Average
150.98M
Median
Total Liabilities (Quarterly) Benchmarks
| Organogenesis Holdings Inc | 167.75M |
| MaxCyte Inc | 35.31M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 293.58M |
| Shareholders Equity (Quarterly) | 87.21M |
| Debt to Equity Ratio | 0.6755 |
| Current Ratio | 3.203 |
| Net Debt Paydown Yield | -0.04% |